REACTIVE ARTHRITIS
https://doi.org/10.14412/1995-4484-2015-414-420
Abstract
At present, the problem of reactive arthritis (ReA) remains relevant in rheumatology. This is due to rather high prevalence of the disease primarily in Russia, which cannot but alarm. Analysis of epidemiological findings suggests a number of possible explanations for variability of ReA incidence rates in some regions of the Russian Federation and other countries. The lecture details the clinical presentations of the disease and analyzes the significance of different laboratory procedures aimed at detecting the pathogen of ReA. It presents Russian diagnostic criteria for ReA. It also sets forth basic approaches to ReA therapy with emphasis on the use of antimicrobial drugs. The efficiency and safety of drug immunomodulation (interferon inducers, polyoxidonium, immunofan, etc.) in treating urogenital Chlamydia infection in ReA patients are not confirmed by the data of randomized controlled trials. In this connection, it is impossible to give any recommendations for their use in urogenic ReA.
About the Authors
B. S. BelovRussian Federation
S. V. Shubin
Russian Federation
R. M. Balabanova
Russian Federation
Sh. F. Erdes
Russian Federation
References
1. Ford DK. Natural history of arthritis folloving venereal urethritis. Ann Rheum Dis. 1953;12(3):177–97. doi: 10.1136/ard.12.3.177
2. Csonka GW. Significance of sacro-iliitis in Reiter’s disease. Br J Vener Dis. 1959;35:77–80. doi: 10.1136/sti.35.2.77
3. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand. 1969;5:232–53. doi: 10.3109/rhe1.1969.15.issue-1-4.32
4. Panush RS, Wallace DJ, Dorff RE, Engleman EP. Retraction of the suggestion to use the term «Reiter’s syndrome» sixty-five years later: the legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum. 2007;56(2):693–4. doi: 10.1002/art.22374
5. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011;25(3):347–57. doi: 10.1016/j.berh.2011.01.018
6. Inman RD. Reactive arthritis. In: Hochberg ML, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 6th ed. Philadelphia: Mosby; 2015. P. 928–40.
7. Zeidler H, Hudson AP. New insights into Chlamydia and arthritis. Promise of a cure? Ann Rheum Dis. 2014;73:637–44. doi: 10.1136/annrheumdis-2013-204110
8. Агабабова ЭР, Бунчук НВ, Шубин СВ и др. Критерии диагноза реактивных артритов (проект). Научно-практическая ревматология 2003;(3):82–3 [Agababova ER., Bunchuk NV, Shubin SV, et al. The criteria for the diagnosis of reactive arthritis (draft). Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2003;(3):82–3 (In Russ.)].
9. Ковалев ЮН, Ильин НИ. Болезнь Рейтера. Челябинск: Вариант-книга; 1993. 240 с. [Kovalev YгN, Il'in NI. Bolezn' Rejtera [Reiter’s disease]. Chelyabinsk: Variant-kniga; 1993. 240 p.].
10. Carter JD, Espinosa LR, Inman RD, et al Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 2010;62(5):1298–307. doi: 10.1002/art.27394
Review
For citations:
Belov B.S., Shubin S.V., Balabanova R.M., Erdes Sh.F. REACTIVE ARTHRITIS. Rheumatology Science and Practice. 2015;53(4):414-420. (In Russ.) https://doi.org/10.14412/1995-4484-2015-414-420